Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842608 · ClinicalTrials.gov registry record · NA
Pharmacological Management of Delirium
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 551
- Enrollment target
NCT00842608 is a NA study that has completed, run by Indiana University. The registered enrollment target is 551 participants.
The verdict
NCT00842608, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 551 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and test the feasibility of using a specific pharmacological protocol to reduce delirium burden among older adults in the Intensive Care Unit (ICU). The study will test the efficacy of a pharmacological intervention in reducing delirium severity and duration as well as length of stay and mortality compared to usual care.
Interventions
- DRUG Haloperidol
- PROCEDURE Usual care
- BEHAVIORAL Reduced exposure to anticholinergics
- PROCEDURE Reduced exposure to benzodiazepines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 551 participants |
| Start Date | 2009-02 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00842608
The ClinicalTrials.gov registry entry for NCT00842608 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 551 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Haloperidol is the first listed.
NCT00842608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00842608 about?
NCT00842608 is a clinical study titled "Pharmacological Management of Delirium". The purpose of this study is to develop and test the feasibility of using a specific pharmacological protocol to reduce delirium burden among older adults in the Intensive Care Unit (ICU). The study will test the efficacy of a pharmacological intervention in reducing delirium severity and duration a...
What is the current status of trial NCT00842608?
This trial is currently completed. It is a NA study. The enrollment target is 551 participants. The study started on 2009-02. Estimated completion is 2015-07.
What interventions are being tested in trial NCT00842608?
The interventions under investigation include: Haloperidol (DRUG), Usual care (PROCEDURE), Reduced exposure to anticholinergics (BEHAVIORAL), Reduced exposure to benzodiazepines (PROCEDURE).
Who is sponsoring clinical trial NCT00842608?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.